Phosphoglycerate Kinase Deficiency Due to a Novel Mutation (c. 1180A>G) Manifesting As Chronic Hemolytic Anemia in a Japanese Boy

Overview

Journal Int J Hematol

Specialty Hematology

Date 2014 Jun 18

PMID 24934115

Citations 5

Authors

Masato Tamai

Takeshi Kawano

Ryota Saito

Ken Sakurai

Yoshihiro Saito

Hisashi Yamada

Hiroyuki Ida

Masaharu Akiyama

Affiliations

Soon will be listed here.

Abstract

Phosphoglycerate kinase (PGK) deficiency, a rare X-linked inherited disorder, manifests as various combinations of hemolytic anemia, neurological dysfunction, and myopathy. We report a Japanese boy with PGK deficiency presenting as chronic hemolytic anemia. The diagnosis of PGK1 deficiency was made at 11 months of age on the basis of low PGK enzyme activity (36.7 IU/g Hb; normal, 264-326 IU/g Hb) and the identification through PGK1 gene sequencing of a novel missense mutation: c. 1180A>G at exon 10. The mutation, which has been designated PGK-Aoto, results in a Thr394Ala amino-acid substitution at β-strand L. Because β-strand L plays an important role in the function of the hinge connecting the two domains of PGK, the Thr394Ala substitution may perturb this motion. At 3 years of age the patient has transfusion-dependent hemolytic anemia but no evidence of neuromuscular disease or developmental delay. Long-term follow-up will be needed to identify possible future clinical manifestations.

Citing Articles

A Mild Clinical Phenotype with Myopathic and Hemolytic Forms of Phosphoglycerate Kinase Deficiency (PGK Osaka): A Case Report and Literature Review.

Baba K, Fukuda T, Furuta M, Tada S, Imai A, Asano Y Intern Med. 2022; 61(23):3589-3594.

PMID: 35527021 PMC: 9790788. DOI: 10.2169/internalmedicine.9221-21.

A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population.

Garcia-Solaesa V, Serrano-Lorenzo P, Ramos-Arroyo M, Blazquez A, Pagola-Lorz I, Artigas-Lopez M Genes (Basel). 2019; 10(10).

PMID: 31658606 PMC: 6826351. DOI: 10.3390/genes10100785.

A novel mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria.

Matsumaru S, Oguni H, Ogura H, Shimojima K, Nagata S, Kanno H Intractable Rare Dis Res. 2017; 6(2):132-136.

PMID: 28580215 PMC: 5451746. DOI: 10.5582/irdr.2017.01020.

Skeletal muscle disorders of glycogenolysis and glycolysis.

Godfrey R, Quinlivan R Nat Rev Neurol. 2016; 12(7):393-402.

PMID: 27231184 DOI: 10.1038/nrneurol.2016.75.

Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene.

David D, Almeida L, Maggi M, Araujo C, Imreh S, Valentini G JIMD Rep. 2015; 23:55-65.

PMID: 25814383 PMC: 4484905. DOI: 10.1007/8904_2015_427.

References

Fujii H, Kanno H, Hirono A, Shiomura T, Miwa S . A single amino acid substitution (157 Gly----Val) in a phosphoglycerate kinase variant (PGK Shizuoka) associated with chronic hemolysis and myoglobinuria. Blood. 1992; 79(6):1582-5. View

Ookawara T, Dave V, Willems P, Martin J, de Barsy T, Matthys E . Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant. Arch Biochem Biophys. 1996; 327(1):35-40. DOI: 10.1006/abbi.1996.0089. View

Hamano T, Mutoh T, Sugie H, Koga H, Kuriyama M . Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation. Neurology. 2000; 54(5):1188-90. DOI: 10.1212/wnl.54.5.1188. View

Fujii H, Krietsch W, Yoshida A . A single amino acid substitution (Asp leads to Asn) in a phosphoglycerate kinase variant (PGK München) associated with enzyme deficiency. J Biol Chem. 1980; 255(13):6421-3. View

Rhodes M, Ashford L, Manes B, Calder C, Domm J, Frangoul H . Bone marrow transplantation in phosphoglycerate kinase (PGK) deficiency. Br J Haematol. 2011; 152(4):500-2. DOI: 10.1111/j.1365-2141.2010.08474.x. View

Svaasand E, Aasly J, Landsem V, Klungland H . Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency. Muscle Nerve. 2007; 36(5):679-84. DOI: 10.1002/mus.20859. View

Maeda M, Yoshida A . Molecular defect of a phosphoglycerate kinase variant (PGK-Matsue) associated with hemolytic anemia: Leu----Pro substitution caused by T/A----C/G transition in exon 3. Blood. 1991; 77(6):1348-52. View

Fermo E, Bianchi P, Chiarelli L, Maggi M, Mandara G, Vercellati C . A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. Mol Genet Metab. 2012; 106(4):455-61. DOI: 10.1016/j.ymgme.2012.05.015. View

Flanagan J, Rhodes M, Wilson M, Beutler E . The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006; 134(2):233-7. DOI: 10.1111/j.1365-2141.2006.06143.x. View

10.

Shirakawa K, Takahashi Y, Miyajima H . Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing. Neurology. 2006; 66(6):925-7. DOI: 10.1212/01.wnl.0000203500.63884.39. View

11.

Morimoto A, Ueda I, Hirashima Y, Sawai Y, Usuku T, Kano G . A novel missense mutation (1060G --> C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis. Br J Haematol. 2003; 122(6):1009-13. DOI: 10.1046/j.1365-2141.2003.04543.x. View

12.

Fujii H, Chen S, Akatsuka J, Miwa S, Yoshida A . Use of cultured lymphoblastoid cells for the study of abnormal enzymes: molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia. Proc Natl Acad Sci U S A. 1981; 78(4):2587-90. PMC: 319394. DOI: 10.1073/pnas.78.4.2587. View

13.

Beutler E . PGK deficiency. Br J Haematol. 2007; 136(1):3-11. DOI: 10.1111/j.1365-2141.2006.06351.x. View

14.

Tsujino S, Tonin P, Shanske S, Nohria V, Boustany R, Lewis D . A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann Neurol. 1994; 35(3):349-53. DOI: 10.1002/ana.410350316. View

15.

Ramirez-Bajo M, Repiso A, de la Ossa P, Banon-Maneus E, de Atauri P, Climent F . Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation. Blood Cells Mol Dis. 2011; 46(3):206-11. DOI: 10.1016/j.bcmd.2010.12.009. View

16.

Rosa R, George C, Fardeau M, Calvin M, Rapin M, Rosa J . A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia. Blood. 1982; 60(1):84-91. View

17.

Valentin C, Birgens H, Craescu C, Cohen-Solal M . A phosphoglycerate kinase mutant (PGK Herlev; D285V) in a Danish patient with isolated chronic hemolytic anemia: mechanism of mutation and structure-function relationships. Hum Mutat. 1998; 12(4):280-7. DOI: 10.1002/(SICI)1098-1004(1998)12:4<280::AID-HUMU10>3.0.CO;2-V. View

18.

Fujii H, Yoshida A . Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia. Proc Natl Acad Sci U S A. 1980; 77(9):5461-5. PMC: 350080. DOI: 10.1073/pnas.77.9.5461. View

19.

Sugie H, Sugie Y, Nishida M, Ito M, Tsurui S, Suzuki M . Recurrent myoglobinuria in a child with mental retardation: phosphoglycerate kinase deficiency. J Child Neurol. 1989; 4(2):95-9. DOI: 10.1177/088307388900400203. View

20.

Maeda M, Bawle E, Kulkarni R, Beutler E, Yoshida A . Molecular abnormalities of a phosphoglycerate kinase variant generated by spontaneous mutation. Blood. 1992; 79(10):2759-62. View